Persistent depletion of striatal dopamine and cortical norepinephrine in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol (MPTP-3-OL), an analog of MPTP
- 31 December 1992
- journal article
- Published by Elsevier in Life Sciences
- Vol. 50 (8) , 573-582
- https://doi.org/10.1016/0024-3205(92)90369-z
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Tissue concentrations of MPTP and MPP+ in relation to catecholamine depletion after the oral or subcutaneous administration of MPTP to miceLife Sciences, 1988
- Persistent depletion of striatal dopamine and its metabolites in mice by TMMP, an analogue of MPTPJournal of Pharmacy and Pharmacology, 1987
- I. The development of amine substituted analogues of MPTP as unique tools for the study of MPTP toxicity and Parkinson's diseaseLife Sciences, 1987
- Persistent depletion of striatal dopamine in mice by 1-Methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine (MTTP)Biochemical Pharmacology, 1986
- Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and several of its analogues on the dopaminergic nigrostriatal pathway in miceNeuroscience Letters, 1985
- VI. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: Relationships between monoamine oxidase, MPTP metabolism and neurotoxicityLife Sciences, 1985
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- The interaction between reversible and irreversible monoamine oxidase inhibitorsBiochemical Pharmacology, 1960